论文部分内容阅读
目前肺癌的发生率已居恶性肿瘤首位,大多数患者就诊时已失去手术机会或难以耐受手术,而放化疗毒副作用较大,其中放射性肺损伤是限制放疗疗效的重要因素。本研究对90例放疗的肺癌患者用参芪扶正注射液联合放疗取得明显效果。1材料与方法1.1临床资料2013年9月至2015年2月本院收治的原发性肺癌患者90例,均经病理细胞学检查确诊;年龄18~75岁;体力状况改善(KPS)评分≥70分,白细胞计数
At present, the incidence of lung cancer ranks the first place in malignant tumors. Most of the patients have lost the chance of surgery or are intolerant of surgery at the time of diagnosis. The side effects of radiotherapy and chemotherapy are large. Radiological lung injury is an important factor that limits the efficacy of radiotherapy. The study of 90 cases of lung cancer patients with Shenqi Fuzheng injection combined with radiotherapy achieved significant results. 1 Materials and Methods 1.1 Clinical data September 2013 to February 2015 90 cases of primary lung cancer patients admitted to our hospital were confirmed by pathological cytology; aged 18 to 75 years; improved physical fitness (KPS) score ≥ 70 points, white blood cell count